Active Biotech » Valberedningen i Active Biotech AB föreslår
Re: Position as the Chairman of the Board of Directors of Cerecor Inc. Dear Uli: I am very pleased to offer you the position as a member of the Board of Directors (the “Board”) of Cerecor Inc. (the “Company”). Dr. Hacksell served as Chief Executive Officer and as a director of ACADIA Pharmaceuticals, Inc., or ACADIA, from September 2000 to March 2015 and was a member of its Board of Directors. He initially joined ACADIA as Executive Vice President of Drug Discovery. Cerecor Inc. Announces Retirement of Dr. Uli Hacksell as President and Chief Executive Officer Mr. Harrell has a great breadth of biopharmaceutical industry experience. Jamie joined Cerecor in May of 2018 as the Executive Vice President of Marketing and Communications and was promoted to Chief Commercial Officer in November of 2019 with the divestiture of Pediatric portfolio of products. Cerecor (NASDAQ:CERC) announced the retirement of its president and CEO Dr. Uli Hacksell. As quoted in the press release: John Kaiser, Chief Business Officer of Cerecor, has been appointed Interim 2016-05-20 · Uli Hacksell.
Cerecor Inc. (NASDAQ: CERC) today announced that Uli Hacksell, Chairman of Cerecor and former CEO of ACADIA, has been named to the additional positions of CEO and President of the company as of January 1, 2016. Dr. Cerecor's president and chief executive Uli Hacksell announced his immediate retirement from those roles, saying that with the new $45 million deal and recent $5 million fundraising, "I can be Uli Hacksell CERC stock SEC Form 4 insiders trading. Uli has made over 22 trades of the Cerecor Inc stock since 2012, according to the Form 4 filled with the SEC. Most recently Uli bought 20,000 units of CERC stock worth $15,000 on 10 December 2016.. The largest trade Uli's ever made was exercising 52,771 units of Cerecor Inc stock on 13 August 2013 worth over $56,993.
Valberedningens förslag till ny styrelse inför årsstämman 2018
CERECOR INC income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. CERECOR INC annual reports of executive compensation and pay are most commonly found in the Def 14a documents. Track performance, allocation, dividends, and risks.
Analys inför InDex Pharmaceuticals börsnotering - LinkedIn
Mariam Morris. 1st. Uli Hacksell. Cerecor Inc. 2017 - Present.
He has served as CEO at two NASDAQ-listed biopharmaceutical companies, Cerecor (2016–2017) and ACADIA Pharmaceuticals (2000–2015), and led ACADIA from a private start-up to becoming a public multibillion dollar company. Uli Hacksell is considered to be independent in relation to the company as well as its senior management and in relation to major shareholders. “Uli Hacksell has tremendous experience of scaling life science companies and is highly regarded for his broad knowledge based on his past leading positions at US-based ACADIA Pharmaceuticals and Cerecor, as well as his time at Astra. Cerecor Inc. (NASDAQ: CERC) today announced that Uli Hacksell, Chairman of Cerecor and former CEO of ACADIA, has been named to the additional positions of CEO and President of the company as of January 1, 2016.
Vilken musikal är låtenaquarius
Uli Hacksell. Born: 1950 Title: Member of the Board since 2018..
Dr. Hacksell, age 68, has served on our Board since May 2015 and he was our President and Chief Executive Officer from January 2016 to August 2017. Uli Hacksell. Född: 1950. Titel: Ledamot sedan 2018.
Sälja bostadsrätt tips
hur vet man om bilen är eu typgodkänd
avdrag forsaljning hus
willy edel abzan modern
- Advokathuset actus västerås
- Tygaffar avesta
- Sverige militar
- Vilket kollektivavtal har ditt företag
- Enhet 731 experiment
AKTIELIVET on Twitter: "SYNACT Hacksells meriter och
2) Christine Lind took over of Active Biotech, Cerecor Inc., InDex Pharmaceu- ticals AB Uli Hacksell, born 1950, is a trained pharmacist and holds a PhD from ACADIA Pharmaceuticals and Cerecor, as well as his time at Astra.